Valuation: CellaVision AB

Market Cap 3.3B 342M 300M 276M 255M 484M 32.66B 492M 1.3B 16.09B 1.29B 1.26B 55.31B P/E 2026 *
24.4x
P/E 2027 * 19.5x
Enterprise Value 3.09B 320M 280M 258M 239M 453M 30.54B 460M 1.21B 15.04B 1.2B 1.18B 51.72B EV / Sales 2026 *
4.07x
EV / Sales 2027 * 3.59x
Free-Float
83.08%
Yield 2026 *
1.99%
Yield 2027 * 2.3%
1 day+2.67%
1 week-5.46%
Current month+1.62%
1 month+9.84%
3 months-8.34%
6 months-14.04%
Current year-11.96%
1 week 132
Extreme 132
148
1 month 132
Extreme 132
154.4
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 63.25
Extreme 63.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
Jun. 11Buy 760 0.0032%
Jun. 08Buy

Founder

33,000 0.1384%
Jun. 08Buy

Director

314 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+2.67%-5.46%-26.93%-24.21% 342M
+3.73%+6.80%+7.08%-21.25% 17.28B
+3.87%-5.71%+14.87%+96.15% 1.68B
+4.76%+0.11%-42.09%-78.52% 1.25B
-2.75%-6.73%-32.90%+29.18% 1.06B
+2.92%-2.22%-29.06%-54.36% 626M
+3.91%-4.74%-40.38%-56.87% 555M
+2.60%+4.15%+29.39%-52.33% 466M
+1.13%-0.48%-55.67%-59.51% 380M
-0.37%-6.79%+12.19%+7.14% 306M
Average +2.25%-1.48%-16.35%-21.46% 2.4B
Weighted average by Cap. +3.36%+4.30%+0.27%-16.32%

Financials

2026 *2027 *
Net sales 759M 78.72M 68.86M 63.51M 58.66M 111M 7.51B 113M 298M 3.7B 296M 289M 12.72B 849M 88.08M 77.05M 71.07M 65.64M 125M 8.4B 127M 333M 4.14B 331M 324M 14.23B
Net income 135M 14.02M 12.26M 11.31M 10.45M 19.82M 1.34B 20.16M 53.08M 659M 52.64M 51.5M 2.26B 173M 17.97M 15.72M 14.5M 13.39M 25.41M 1.71B 25.84M 68.03M 844M 67.47M 66M 2.9B
Net Debt -214M -22.25M -19.46M -17.95M -16.58M -31.46M -2.12B -31.99M -84.22M -1.05B -83.53M -81.72M -3.59B -251M -26.08M -22.81M -21.04M -19.44M -36.88M -2.49B -37.5M -98.74M -1.23B -97.93M -95.8M -4.21B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
26-07-10 SEK 138.40 +2.67% 12,538
26-07-09 SEK 134.80 +2.12% 16,039
26-07-08 SEK 132.00 -3.37% 32,326
26-07-07 SEK 136.60 -4.74% 39,551
26-07-06 SEK 143.40 -2.05% 18,390
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
138.40SEK
Average target price
168.75SEK
Spread / Average Target
+21.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock